Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease

被引:45
作者
Bloem, B. R. [1 ]
Stocchi, F. [2 ]
机构
[1] Radboud Univ Nijmegen, Parkinson Ctr Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav,Dept Neurol, NL-6500 HB Nijmegen, Netherlands
[2] IRCCS San Raffaele, Inst Res & Med Care, Dept Neurol, Rome, Italy
关键词
Charter; diagnosis; EPDA; European survey; guidelines; Parkinson's disease; quality of care; treatment; JOINT TASK-FORCE; QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; THERAPEUTIC MANAGEMENT; NEUROLOGICAL SOCIETIES; DISORDER SOCIETY; HEALTH-CARE; DIAGNOSIS; COST; FEDERATION;
D O I
10.1111/j.1468-1331.2011.03532.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background and purpose: The 1997 European Parkinsons Disease Associations (EPDA) Charter for People with Parkinsons disease (PD) outlines their rights in terms of standards of care. It states that all patients have the right to: be referred to a doctor with a special interest in PD; receive an accurate diagnosis; have access to support services; receive continuous care; and take part in managing their illness. Move for Change is a three-part series of pan-European patient surveys based on this Charter. Methods: This first survey, consisting of 23 questions, focusing on the initial two points of the Charter, was administered online through the EPDA and affiliated patient associations' Web sites. Of 2149 forms received from 35 European countries, 2068 (96.2%) were analyzed, with the remainder excluded, mainly due to incomplete responses. Results: The majority of patients were diagnosed within 2 years from the onset of first symptoms (82.7%; range, < 1 year to 5 years). In relation to diagnosis delivery, 45.3% of patients stated that it was 'poor' or 'very poor'. During the 2 years following diagnosis, 43.8% of respondents had never seen a PD specialist. Care was usually overseen by generically active neurologists (92.5%) or family doctors (81.0%), with considerable overlap between the two. Conclusions: These data highlight challenges that patients with PD face during the period of diagnosis, despite introduction of the Charter. These findings can assist healthcare professionals and policy makers in improving the level of care for patients and their families across Europe, and we offer suggestions about how this can be achieved.
引用
收藏
页码:402 / E26
页数:11
相关论文
共 48 条
[1]
Cost of disorders of the brain in Europe [J].
Andlin-Sobocki, P ;
Jönsson, B ;
Wittchen, HU ;
Olesen, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 :1-+
[2]
The journey: Parkinson's disease [J].
Baker, MG ;
Graham, L .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7466) :611-614
[3]
The Genetics of Parkinson Disease [J].
Bekris, Lynn M. ;
Mata, Ignacio F. ;
Zabetian, Cyrus P. .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2010, 23 (04) :228-242
[4]
Bloem B R., 2010, Multidisciplinaire Richtlijn 'Ziekte van Parkinson'
[5]
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment [J].
Chaudhuri, K. Ray ;
Schapira, Anthony H. V. .
LANCET NEUROLOGY, 2009, 8 (05) :464-474
[6]
Non-motor symptoms of Parkinson's disease: diagnosis and management [J].
Chaudhuri, KR ;
Healy, DG ;
Schapira, AHV .
LANCET NEUROLOGY, 2006, 5 (03) :235-245
[7]
Chen JJ, 2010, AM J MANAG CARE, V16, pS87
[8]
Association of specialist involvement and quality of care for Parkinson's disease [J].
Cheng, Eric M. ;
Swarztrauber, Kari ;
Siderowf, Andrew D. ;
Eisa, Mahmood S. ;
Lee, Martin ;
Vassar, Stefanie ;
Jacob, Erin ;
Vickrey, Barbara G. .
MOVEMENT DISORDERS, 2007, 22 (04) :515-522
[9]
Increasing Access to Specialty Care: A Pilot, Randomized Controlled Trial of Telemedicine for Parkinson's Disease [J].
Dorsey, E. Ray ;
Deuel, Lisa M. ;
Voss, Tiffini S. ;
Finnigan, Kara ;
George, Benjamin P. ;
Eason, Sheelah ;
Miller, David ;
Reminick, Jason I. ;
Appler, Anna ;
Polanowicz, Joyce ;
Viti, Lucy ;
Smith, Sandy ;
Joseph, Anthony ;
Biglan, Kevin M. .
MOVEMENT DISORDERS, 2010, 25 (11) :1652-1659
[10]
European Parkinson's Disease Association (EPDA), EFDA CHART